GlassScriptPhysician profile
Dean R Lindstrom, III
NPI 1033184304
$1,938.41
in general payments reported to CMS, 2019-2025
22 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $96.73 · 2021: $158 · 2022: $160 · 2023: $303 · 2024: $303 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,327 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.83 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $419.79 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $299.11 | 2019-2025 | Dupixent |
| Genzyme Corporation | $255.04 | 2022-2025 | |
| Alk-Abello, INC | $171.43 | 2019-2024 | Ragwitek, Grastek, Odactra |
| Glaxosmithkline, LLC. | $101.11 | 2024-2025 | Nucala |
| Integra Lifesciences Corporation | $85.42 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Amgen INC. | $76.51 | 2025 | Tezspire |
| Intersect Ent, INC. | $69.79 | 2019-2021 | |
| Stryker Corporation | $65.33 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $52.82 | 2025 | Voquezna |
| Hikma Pharmaceuticals USA | $51.11 | 2023-2025 | Ryaltris |
| Merck Sharp & Dohme LLC | $35.47 | 2023-2025 | Keytruda |
| Aerin Medical INC. | $33.73 | 2025 | |
| Medtronic, INC. | $31.51 | 2024 | Propel |
| Acclarent, INC | $30.29 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $26.59 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $25.12 | 2025 | Neffy |
| Tactile Systems Technology INC | $24.68 | 2021 | |
| Photonicare INC | $24.65 | 2023 | Otosight Middle Ear Scope |
| Paratek Pharmaceuticals, INC. | $20.12 | 2025 | Xhance |
| Inspire Medical Systems, INC. | $19.79 | 2024 | Inspire |
| Glenmark Therapeutics INC. | $19.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Lindstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.